Research opportunities at 
Washington University Movement Disorders Center
phone 314-362-6026

studies for . . . 
  • family & friends (healthy volunteers)
  • Parkinson's disease
  • tremor
  • dystonia
  • Tourette syndrome or tics
  • Huntington's disease

    CLINICAL FEATURES STUDY (for more information, click on the study name, if highlighted) CONTACT
    Healthy volunteers without a movement disorder (needed as controls for other studies)
    normal, spouse of Parkinson's disease patient PD genetics L. Good
    any adult with no neurological or psychiatric illness or history of substance abuse high-resolution MRI study J. Hartlein
    effects of levodopa on memory and attention T. Hershey
    Parkinson's disease
    all patients with PD PD genetics L. Good
    effects of levodopa on memory and attention T. Hershey
    deep brain stimulation patients = movement kinematics
    = functional imaging study (PET)
    A. Loepker
    patients with diagnosed PD for less than 5 years who do not currently need treatment to determine the effectiveness of an investigational study
    medication (CEP-1347)in slowing disease progression
    P. Deppen
    PD patients who have responded to L-DOPA (Sinemet) at some point = MRI measurement of dopamine function (apomorphine fMRI)
    = functional imaging of levodopa effects on memory and attention
    J. Hartlein
    psychosis (hallucinations) in Parkinson's disease olanzapine J. Hartlein
    patients with PD who have never been treated imaging study of oxidative metabolism L. McGee-Minnich
    PD or essential tremor patients who have had deep brain stimulator surgery = PET study
    = kinematic study
    L. McGee-Minnich
    bilateral essential or Parkinson tremor bilateral thalamic stimulation A. Loepker
    all dystonia genetics study L. Good
    Huntington's disease
    Patients with HD, or at-risk family members = clinical evaluation
    = imaging study of oxidative metabolism
    P. Cooper
    L. McGee-Minnich